A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

2,250

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions
Respiratory Syncytial Virus Infections
Interventions
BIOLOGICAL

TNM001

single dose intramuscular injection

BIOLOGICAL

placebo

single dose intramuscular injection

Trial Locations (39)

100000

Peking University Third Hospital, Beijing

100020

Children's Hospital Capital Institute Pediatrics, Beijing

201102

The affiliated children'shospital fudan university, Shanghai

250022

Children's Hospital Affiliated to Shandong University, Jinan

310006

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine/Hangzhou First People's Hospital, Hangzhou

315012

Ningbo Women&Children's Hospital, Ningbo

330000

Jiangxi Maternal and Child Health Hospital, Nanchang

361003

Xiamen maternal and Child Health Hospital, Xiamen

400000

Jiangjin Central Hospital, Chongqing

404100

Children's Hospital of Chongqing Medical University, Chongqing

410008

The Maternal and Child Health Hospital of Hunan Province, Changsha

Xiangya Hospital Central South University, Changsha

410013

The Third Xiangya Hospital of Central South University, Changsha

415000

The First People'S Hospital of Changde City, Changde

417099

Loudi Central Hospital, Loudi

421001

The Second Hospital University of South China, Hengyang

422000

The First Affiliated Hospital of Shaoyang University, Shaoyang

430060

Renmin Hospital of Wuhan University, Wuhan

The Central Hospital of Wuhan, Wuhan

450052

Henan (Zhengzhou) Children's Hospital, Zhengzhou

453000

Xinxiang First People's Hospital, Xinxiang

472000

Sanmenxia Central Hospital, Sanmenxia

510150

The Third Affiliated Hospital of Guangzhou Medical University, Guangdong

511442

Guangdong Maternal and Child Health Care Hospital, Guangzhou

518000

University of Chinese Academy of Sciense Shenzhen Hospital, Shenzhen

530002

Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning

541001

Affiliated Hospital of Guilin Medical University, Guilin

545006

LiuZhou People's Hospital, Liuzhou

570312

HaiNan Women and Children's Medical Center, Haikou

610000

Chengdu Women's and Children's Central Hospital, Chengdu

West China Second University Hospital, Sichuan University, Chengdu

621000

Mianyang Peoples Hospital, Mianyang

065000

Hebei Petro China Central Hospital, Langfang

050000

The Fourth Hospital of Hebei Medical University, Shijiazhuang

The Second Hospital of HeBei Medical University (HBMU), Shijiazhuang

063000

Tangshan Maternal and Child Health Hospitaltangshan Maternal and Child Health Hospital, Tangshan

041000

Linfen Central Hospital, Linfen

Linfen People's Hospital, Linfen

044000

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Zhuhai Trinomab Pharmaceutical Co., Ltd.

INDUSTRY

NCT06083623 - A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants | Biotech Hunter | Biotech Hunter